Skip to main content
Erschienen in: Annals of Hematology 2/2004

01.02.2004 | Original Article

TNF-α induces changes in LDH isotype profile following triggering of apoptosis in PBL of non-Hodgkin’s lymphomas

verfasst von: V. Jurisic, V. Bumbasirevic, G. Konjevic, B. Djuricic, I. Spuzic

Erschienen in: Annals of Hematology | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

Based on the possibility of tumor necrosis factor (TNF)-α to perform multiple and opposite biologic effects, we simultaneously investigated in vitro its effects on intracellular lactate dehydrogenase (LDH)-H and LDH-M isoenzyme activity and morphological characteristics following induction of apoptosis in peripheral blood mononuclear cells (PBMC) of non-Hodgkin’s lymphoma patients (NHL) prior to and after the end of applied chemotherapy. TNF-α showed a significant increase (p<0.05) of LDH–H and LDH-M activity in sonified PBMC of healthy controls after 18 h cultures accompanied with an increase of apoptotic index (AI) from 2.3 to 16.2%. Contrary to this, in PBMC of NHL patients prior to therapy TNF-α induced a significant decrease (p<0.05) of LDH-H isotype activity. In patients after administration of chemotherapy, TNF-α in a dose of 100 U/ml induced a significant increase (p<0.05) of LDH-M isotype activity, but not of LDH-H. In the PBMC of NHL patients prior to chemotherapy, TNF-α in vitro induced an increase of AI from 2.8 up to 6.8%, while in PBMC of NHL patients after applied chemotherapy AI changed from 7.2 to 14.4%. However, there was no significant difference in the increase of apoptosis in PBMC of NHL patients with high-grade malignancy and high rate response among patients who received first-line therapy, high-dose therapy, or third-line therapy regimens after in vitro TNF-α treatment. These results indicated different susceptibilities of PBMC of NHL to TNF-α when effects were analyzed by determination of intracellular LDH isotype profile and induction of apoptosis prior to and after administration of therapy in comparison to effects on healthy controls PBMC.
Literatur
1.
Zurück zum Zitat Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, c-stimulation and death. Cell 75:959–962 Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, c-stimulation and death. Cell 75:959–962
2.
Zurück zum Zitat Gruss HJ (1996) Molecular, structural and biological characteristics of the tumor necrosis factor ligand superfamily. Int J Clin Lab Res 26:143–159PubMed Gruss HJ (1996) Molecular, structural and biological characteristics of the tumor necrosis factor ligand superfamily. Int J Clin Lab Res 26:143–159PubMed
3.
Zurück zum Zitat Grell M, Zimmermann G, Hulser D, Pfizenmaier K, Scheurich P (1994) TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J Immunol 153:1963–1972PubMed Grell M, Zimmermann G, Hulser D, Pfizenmaier K, Scheurich P (1994) TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J Immunol 153:1963–1972PubMed
4.
Zurück zum Zitat Zheng C, Fischer G, Miller RE, Peschon J, Lynch DH, Lenardo MJ (1995) Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348–352 Zheng C, Fischer G, Miller RE, Peschon J, Lynch DH, Lenardo MJ (1995) Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348–352
5.
Zurück zum Zitat Pasparakis M, Alexopoulou L, Episkopou V, Kollias G (1996) Immune and inflammatory response in TNF-α in formation of primary B cell follicles, follicular dendritic networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1397–1411PubMed Pasparakis M, Alexopoulou L, Episkopou V, Kollias G (1996) Immune and inflammatory response in TNF-α in formation of primary B cell follicles, follicular dendritic networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1397–1411PubMed
6.
Zurück zum Zitat Hafner M, Orosz P, Kruger A, Mannel DN (1996) TNF promotes metastasis by impairing natural killer cell activity. Int J Cancer 66:388–392CrossRefPubMed Hafner M, Orosz P, Kruger A, Mannel DN (1996) TNF promotes metastasis by impairing natural killer cell activity. Int J Cancer 66:388–392CrossRefPubMed
7.
Zurück zum Zitat Wyllie AH (1995) Apoptosis: cell death in tissue regulation. J Pathol 153:313–316 Wyllie AH (1995) Apoptosis: cell death in tissue regulation. J Pathol 153:313–316
8.
Zurück zum Zitat Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462PubMed Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462PubMed
9.
Zurück zum Zitat Sachs L, Lotem J (1993) Control of programmed cell death in normal and leukemic cells: new implication for therapy. Blood 82:25–21 Sachs L, Lotem J (1993) Control of programmed cell death in normal and leukemic cells: new implication for therapy. Blood 82:25–21
10.
Zurück zum Zitat Vajant H, Scheurich P (2001) Tumor necrosis factor receptor-associated factor (TRAF2) and its role in TNF signaling. Int J Biochem Cell Biol 33:19–32CrossRefPubMed Vajant H, Scheurich P (2001) Tumor necrosis factor receptor-associated factor (TRAF2) and its role in TNF signaling. Int J Biochem Cell Biol 33:19–32CrossRefPubMed
11.
Zurück zum Zitat Yoshida N, Ishii E, Mohri S, Nagumo F, Yoshidomi S, Miyazaki S (1999) Suppression of growth and dissemination in human pre-B leukemia cells by tumor necrosis factor-a in Scid mice. Leuk Lymphoma 33:107–118PubMed Yoshida N, Ishii E, Mohri S, Nagumo F, Yoshidomi S, Miyazaki S (1999) Suppression of growth and dissemination in human pre-B leukemia cells by tumor necrosis factor-a in Scid mice. Leuk Lymphoma 33:107–118PubMed
12.
Zurück zum Zitat Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Schuh JC, Lynch D (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157–163CrossRefPubMed Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Schuh JC, Lynch D (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157–163CrossRefPubMed
13.
Zurück zum Zitat Hieber U, Heim ME (1994) Tumor necrosis factor for the treatment of malignancies. Oncology 51:142–145PubMed Hieber U, Heim ME (1994) Tumor necrosis factor for the treatment of malignancies. Oncology 51:142–145PubMed
14.
Zurück zum Zitat Licht T, Lubbert M, Martens K, Bross JK, Fiebig HH, Mertelsmann R, Hermann F (1995) Modulation of vindensine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-α. Cytokines Cell Mol Ther 1:123–132 Licht T, Lubbert M, Martens K, Bross JK, Fiebig HH, Mertelsmann R, Hermann F (1995) Modulation of vindensine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-α. Cytokines Cell Mol Ther 1:123–132
15.
Zurück zum Zitat Zinzani PL, Baccini C, Zaccaria A, Visani G, Buzzi M, Morelli A, Molinari AL, Salvucci M, Bendani M, Rubboli D, Gherlinzoni F, Zanchini R, Tura S (1996) Clinical implications of serum level of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin’s lymphoma. Eur J Haematol 57:335–340 Zinzani PL, Baccini C, Zaccaria A, Visani G, Buzzi M, Morelli A, Molinari AL, Salvucci M, Bendani M, Rubboli D, Gherlinzoni F, Zanchini R, Tura S (1996) Clinical implications of serum level of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin’s lymphoma. Eur J Haematol 57:335–340
16.
Zurück zum Zitat Salles G, Bienvenu J, Bastion Y, Doche C, Warzocha K, Gutowski MC, Rieuz C, Coffier B (1996) Elevated circulating level of TNF-α and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Haematol 93:352–359PubMed Salles G, Bienvenu J, Bastion Y, Doche C, Warzocha K, Gutowski MC, Rieuz C, Coffier B (1996) Elevated circulating level of TNF-α and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Haematol 93:352–359PubMed
17.
Zurück zum Zitat Jurisic V, Colovic M (2002) Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta-2 microglobulin, and clinical stage in multiple myeloma, Med Oncol 19:133–139 Jurisic V, Colovic M (2002) Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta-2 microglobulin, and clinical stage in multiple myeloma, Med Oncol 19:133–139
18.
Zurück zum Zitat Ross ME, Caligiuri MA (1997) Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89:910–918PubMed Ross ME, Caligiuri MA (1997) Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89:910–918PubMed
19.
Zurück zum Zitat Spaggiari GM, Contini P, Dondero A, Carosio R, Puppo F, Indiveri F, Raffaella-Zocchi M, Poggi A (2002) Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood 100:4098–4107CrossRefPubMed Spaggiari GM, Contini P, Dondero A, Carosio R, Puppo F, Indiveri F, Raffaella-Zocchi M, Poggi A (2002) Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood 100:4098–4107CrossRefPubMed
20.
Zurück zum Zitat The Non-Hodgkin’s Lymphoma Pathologic Classification Project (1982) National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas. Summary and description of a working formulation for clinical usage. Cancer 49:2112–2135PubMed The Non-Hodgkin’s Lymphoma Pathologic Classification Project (1982) National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas. Summary and description of a working formulation for clinical usage. Cancer 49:2112–2135PubMed
21.
Zurück zum Zitat Jurisic V, Konjevic G, Banicevic B, Djuricic B, Spuzic I (2000) Different alterations in lactate dehydrogenase activity and profile of peripheral blood mononuclear cells in Hodgkin’s and non-Hodgkin’s lymphomas. Eur J Haematol 64:259–266CrossRefPubMed Jurisic V, Konjevic G, Banicevic B, Djuricic B, Spuzic I (2000) Different alterations in lactate dehydrogenase activity and profile of peripheral blood mononuclear cells in Hodgkin’s and non-Hodgkin’s lymphomas. Eur J Haematol 64:259–266CrossRefPubMed
22.
Zurück zum Zitat Bumbasirevic V, Milicic-Skaro A, Mircic A, Djuricic B (1995) Apoptosis induced by microtubule disrupting drugs in normal murine thymocytes in vitro. Scanning Microsc 9:509–518PubMed Bumbasirevic V, Milicic-Skaro A, Mircic A, Djuricic B (1995) Apoptosis induced by microtubule disrupting drugs in normal murine thymocytes in vitro. Scanning Microsc 9:509–518PubMed
23.
Zurück zum Zitat Binder C, Schulz M, Hiddemann W, Oellerich M (1999) Caspase-activation and induction of inducible nitric oxide-synthase during TNF alpha-triggered apoptosis. Anticancer Res 19:1715–1720PubMed Binder C, Schulz M, Hiddemann W, Oellerich M (1999) Caspase-activation and induction of inducible nitric oxide-synthase during TNF alpha-triggered apoptosis. Anticancer Res 19:1715–1720PubMed
24.
Zurück zum Zitat Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC, Wu-Lee YH, Durkop H, Engelmann H, Scheuich P, Wajant H (1999) Induction of the cell death by tumor necrosis factor (TNF) receptor 2, CD 40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18:3034–3039CrossRefPubMed Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC, Wu-Lee YH, Durkop H, Engelmann H, Scheuich P, Wajant H (1999) Induction of the cell death by tumor necrosis factor (TNF) receptor 2, CD 40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18:3034–3039CrossRefPubMed
25.
Zurück zum Zitat Di-Pietro R, Rana R, Vitale M, Centurione MA, Stuppia L, Centurione L, Santavenere E (1997) TNF-alpha-induced apoptosis in Daudi cells: multiparametric analysis. Cytokine 9:463–470CrossRefPubMed Di-Pietro R, Rana R, Vitale M, Centurione MA, Stuppia L, Centurione L, Santavenere E (1997) TNF-alpha-induced apoptosis in Daudi cells: multiparametric analysis. Cytokine 9:463–470CrossRefPubMed
26.
Zurück zum Zitat Marjanovic S, Skog S, Heiden T, Tribukait B, Nelson BD (1991) Expression of glycolytic enzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. Exp Cell Res 193:425–431PubMed Marjanovic S, Skog S, Heiden T, Tribukait B, Nelson BD (1991) Expression of glycolytic enzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. Exp Cell Res 193:425–431PubMed
27.
Zurück zum Zitat Pan LX, Xu JN, Isaacsons PG (1991) Cellular H and M type lactate dehydrogenase (LDH) isoenzymes and tumor diagnostics: an immunohistochemical assessment. J Pathol 163:53–60PubMed Pan LX, Xu JN, Isaacsons PG (1991) Cellular H and M type lactate dehydrogenase (LDH) isoenzymes and tumor diagnostics: an immunohistochemical assessment. J Pathol 163:53–60PubMed
28.
Zurück zum Zitat Wolberg P, Nelson BD (1992) Regulation of the expression lactate dehydrogenase isoenzymes in human lymphocytes. Mol Cell Biochem 110:161–164PubMed Wolberg P, Nelson BD (1992) Regulation of the expression lactate dehydrogenase isoenzymes in human lymphocytes. Mol Cell Biochem 110:161–164PubMed
29.
Zurück zum Zitat Nehar D, Mausuit C, Boussouar F, Benahmed M (1997) Tumor necrosis factor alpha stimulated lactate production is linked to lactate dehydrogenase A expression and activity increase in porcine cultured Sertoli cells. Endocrinology 138:1964–1971PubMed Nehar D, Mausuit C, Boussouar F, Benahmed M (1997) Tumor necrosis factor alpha stimulated lactate production is linked to lactate dehydrogenase A expression and activity increase in porcine cultured Sertoli cells. Endocrinology 138:1964–1971PubMed
30.
Zurück zum Zitat Konjevic G, Jurisic V, Banicevic B, Spuzic I (1999) The difference in NK cell activity between patients with non-Hodgkin’s lymphomas and Hodgkin’s disease. Br J Haematol 101:104–109 Konjevic G, Jurisic V, Banicevic B, Spuzic I (1999) The difference in NK cell activity between patients with non-Hodgkin’s lymphomas and Hodgkin’s disease. Br J Haematol 101:104–109
31.
Zurück zum Zitat Chen W, Wang HG, Srinivasula SM, Alnemri ES, Cooper NR (1999) B cell apoptosis triggered by antigen receptor ligation proceed via a novel caspase-dependent pathway. J Immunol 163:2489–2491 Chen W, Wang HG, Srinivasula SM, Alnemri ES, Cooper NR (1999) B cell apoptosis triggered by antigen receptor ligation proceed via a novel caspase-dependent pathway. J Immunol 163:2489–2491
32.
Zurück zum Zitat Warzoche K, Ribeiro P, Bienvenu J, Roy P, Chrlot C, Rigal D, Coiffier B, Salles G (1998) Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood 91:3574–3581PubMed Warzoche K, Ribeiro P, Bienvenu J, Roy P, Chrlot C, Rigal D, Coiffier B, Salles G (1998) Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood 91:3574–3581PubMed
33.
Zurück zum Zitat Konjevic G, Jurisic V, Spuzic I (1997) Correction to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity. J Immunol Methods 200:199–201CrossRefPubMed Konjevic G, Jurisic V, Spuzic I (1997) Correction to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity. J Immunol Methods 200:199–201CrossRefPubMed
34.
Zurück zum Zitat Weidmann E, Brieger J, Jahn B, Hoelzer D, Bergmann L, Mitrou PS (1995) Lactate dehydrogenase-release assay: a reliable, non-radioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blast from acute myelocytic leukemia. Ann Hematol 70:153–158CrossRefPubMed Weidmann E, Brieger J, Jahn B, Hoelzer D, Bergmann L, Mitrou PS (1995) Lactate dehydrogenase-release assay: a reliable, non-radioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blast from acute myelocytic leukemia. Ann Hematol 70:153–158CrossRefPubMed
35.
Zurück zum Zitat Jurisic V, Spuzic I, Konjevic G (1999) A comparison of the NK cell cytotoxicity with effects of TNF-alpha against K-562 cell, determined by LDH release assay. Cancer Lett 138:67–72CrossRefPubMed Jurisic V, Spuzic I, Konjevic G (1999) A comparison of the NK cell cytotoxicity with effects of TNF-alpha against K-562 cell, determined by LDH release assay. Cancer Lett 138:67–72CrossRefPubMed
36.
Zurück zum Zitat Pinero J, Lopez-Baena M, Ortiz T, Cortes F (1997) Apoptotic and necrotic cell death are both induced by electroporation in HL60 human promyeloid leukemia cells. Apoptosis 2:330–336 Pinero J, Lopez-Baena M, Ortiz T, Cortes F (1997) Apoptotic and necrotic cell death are both induced by electroporation in HL60 human promyeloid leukemia cells. Apoptosis 2:330–336
37.
Zurück zum Zitat Trubiani O, Ciancarelli M, Rapino M, Di-Primo R (1995) Cytokines and programmed cell death in Burkitt lymphoma cells. Biochem Mol Biol Int 37:17–24PubMed Trubiani O, Ciancarelli M, Rapino M, Di-Primo R (1995) Cytokines and programmed cell death in Burkitt lymphoma cells. Biochem Mol Biol Int 37:17–24PubMed
38.
Zurück zum Zitat Ross ME, Caligiuri AM (1997) Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89:910–918PubMed Ross ME, Caligiuri AM (1997) Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89:910–918PubMed
39.
Zurück zum Zitat Wricht SC, Kumar P, Tam AW, Shwan N, Verma M, Larrick JW (1992) Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 48:344–355PubMed Wricht SC, Kumar P, Tam AW, Shwan N, Verma M, Larrick JW (1992) Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 48:344–355PubMed
40.
Zurück zum Zitat Meilhac O, Escargueil-Blanc I, Thiers JC, Salvayre R, Salvayre-Negre A (1999) Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins. FASEB J 13:485–494PubMed Meilhac O, Escargueil-Blanc I, Thiers JC, Salvayre R, Salvayre-Negre A (1999) Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins. FASEB J 13:485–494PubMed
41.
Zurück zum Zitat Vander Haiden MG, Thompson CB (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1:209–216 Vander Haiden MG, Thompson CB (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1:209–216
42.
Zurück zum Zitat Faraco PR, Ledgerwood EC, Vandenabeele P, Prins JB, Bradley JR (1999) Tumor necrosis factor induces distinct patterns of caspase activation in WEHI-164 cells associated with apoptosis or necrosis depending on cell cycle stage. Biochem Biophys Res Commun 261:385–392CrossRefPubMed Faraco PR, Ledgerwood EC, Vandenabeele P, Prins JB, Bradley JR (1999) Tumor necrosis factor induces distinct patterns of caspase activation in WEHI-164 cells associated with apoptosis or necrosis depending on cell cycle stage. Biochem Biophys Res Commun 261:385–392CrossRefPubMed
43.
Zurück zum Zitat Kumamura S, Ishikura H, Tsumura H, Iwata Y, Endo J, Kobayashi S (1996) c-Myc and Bcl-2 protein expression during the induction of apoptosis and differentiation in TNF-α treated HL-60 cells. Leuk Lymphoma 23:383–394PubMed Kumamura S, Ishikura H, Tsumura H, Iwata Y, Endo J, Kobayashi S (1996) c-Myc and Bcl-2 protein expression during the induction of apoptosis and differentiation in TNF-α treated HL-60 cells. Leuk Lymphoma 23:383–394PubMed
44.
Zurück zum Zitat Genestier M, Revillard JP, Flacher M, Rouault JP, Bonnefoy-Berard N (1995) Tumor necrosis factor-alpha up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell lines. Int Immunol 7:533–540PubMed Genestier M, Revillard JP, Flacher M, Rouault JP, Bonnefoy-Berard N (1995) Tumor necrosis factor-alpha up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell lines. Int Immunol 7:533–540PubMed
45.
Zurück zum Zitat Sachs L, Lotem J (1993) Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82:15–21PubMed Sachs L, Lotem J (1993) Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82:15–21PubMed
46.
Zurück zum Zitat Gamen S, Anel A, Piñeiro A, Naval J (1998) Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the ceramide signalling pathway. Cell Death Differ 5:241–249CrossRefPubMed Gamen S, Anel A, Piñeiro A, Naval J (1998) Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the ceramide signalling pathway. Cell Death Differ 5:241–249CrossRefPubMed
47.
Zurück zum Zitat Okazaki T, Kondo T, Kitano T Tashima M (1998). Diversity and complexity of ceramide signalling in apoptosis. Cell Signal 10:685–692CrossRefPubMed Okazaki T, Kondo T, Kitano T Tashima M (1998). Diversity and complexity of ceramide signalling in apoptosis. Cell Signal 10:685–692CrossRefPubMed
48.
Zurück zum Zitat Kuroki J, Hirokava A, Kitabayashi M, et al. (1996) Cell-permeable ceramide inhibits the growth of B Lymphoma Raji cels lacking TNF-α receptors by inducing G0/G1 arrest but not apoptosis: a new mode for dissecting cell-cycle arrest and apoptosis. Leukemia 10:1950–1958PubMed Kuroki J, Hirokava A, Kitabayashi M, et al. (1996) Cell-permeable ceramide inhibits the growth of B Lymphoma Raji cels lacking TNF-α receptors by inducing G0/G1 arrest but not apoptosis: a new mode for dissecting cell-cycle arrest and apoptosis. Leukemia 10:1950–1958PubMed
49.
Zurück zum Zitat Voelkel-Jonson C, Entingh AJ, Wold SMW (1995) Activation of intracellular proteases is an early event in TNF-induced apoptosis. Immunology 154:1707–1716 Voelkel-Jonson C, Entingh AJ, Wold SMW (1995) Activation of intracellular proteases is an early event in TNF-induced apoptosis. Immunology 154:1707–1716
50.
Zurück zum Zitat Wissing D, Mouritzen H, Egeblad M, Poirier GG, Jaattela M (1997) Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci 94:5073–5077CrossRefPubMed Wissing D, Mouritzen H, Egeblad M, Poirier GG, Jaattela M (1997) Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci 94:5073–5077CrossRefPubMed
51.
Zurück zum Zitat Jurisic V (2003) Estimation of cell membrane alteration after drug treatment by LDH release. Blood 101:2894CrossRefPubMed Jurisic V (2003) Estimation of cell membrane alteration after drug treatment by LDH release. Blood 101:2894CrossRefPubMed
52.
Zurück zum Zitat Williams MA, Newland AC, Kelsey M (2000) Cytokine modulated cell-membrane bound tumor necrosis factor expression is a associated with enhanced monocyte-mediated killing of human leukemic targets. Leuk Res 24:317–330CrossRefPubMed Williams MA, Newland AC, Kelsey M (2000) Cytokine modulated cell-membrane bound tumor necrosis factor expression is a associated with enhanced monocyte-mediated killing of human leukemic targets. Leuk Res 24:317–330CrossRefPubMed
Metadaten
Titel
TNF-α induces changes in LDH isotype profile following triggering of apoptosis in PBL of non-Hodgkin’s lymphomas
verfasst von
V. Jurisic
V. Bumbasirevic
G. Konjevic
B. Djuricic
I. Spuzic
Publikationsdatum
01.02.2004
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 2/2004
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-003-0731-0

Weitere Artikel der Ausgabe 2/2004

Annals of Hematology 2/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.